232 related articles for article (PubMed ID: 30129181)
1. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.
Rompianesi G; Ravikumar R; Jose S; Allison M; Athale A; Creamer F; Gunson B; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A; Tsochatzis E
Liver Int; 2019 Feb; 39(2):353-360. PubMed ID: 30129181
[TBL] [Abstract][Full Text] [Related]
2. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Gurbuz AK; Giardiello FM; Bayless TM
Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
[TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis.
Loftus EV; Sandborn WJ; Tremaine WJ; Mahoney DW; Zinsmeister AR; Offord KP; Melton LJ
Gastroenterology; 1996 Feb; 110(2):432-40. PubMed ID: 8566590
[TBL] [Abstract][Full Text] [Related]
4. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
Poritz LS; Koltun WA
Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
[TBL] [Abstract][Full Text] [Related]
6. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis.
Higashi H; Yanaga K; Marsh JW; Tzakis A; Kakizoe S; Starzl TE
Hepatology; 1990 Mar; 11(3):477-80. PubMed ID: 2312061
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in post-liver transplant recipients.
Sint Nicolaas J; Tjon AS; Metselaar HJ; Kuipers EJ; de Man RA; van Leerdam ME
Dis Colon Rectum; 2010 May; 53(5):817-21. PubMed ID: 20389217
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK
Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.
MacLean AR; Lilly L; Cohen Z; O'Connor B; McLeod RS
Dis Colon Rectum; 2003 Aug; 46(8):1124-8. PubMed ID: 12907911
[TBL] [Abstract][Full Text] [Related]
10. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
11. Incidence and management of colorectal cancer in liver transplant recipients.
Nishihori T; Strazzabosco M; Saif MW
Clin Colorectal Cancer; 2008 Jul; 7(4):260-6. PubMed ID: 18650194
[TBL] [Abstract][Full Text] [Related]
12. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
13. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
[TBL] [Abstract][Full Text] [Related]
14. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts.
Cordes F; Laumeyer T; Gerß J; Brückner M; Lenze F; Nowacki T; Rijcken E; Tepasse P; Schmidt H; Kucharzik T; Bettenworth D
Dis Colon Rectum; 2019 Dec; 62(12):1494-1504. PubMed ID: 31725582
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO
Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034
[TBL] [Abstract][Full Text] [Related]
16. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract][Full Text] [Related]
17. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.
Kornfeld D; Ekbom A; Ihre T
Gut; 1997 Oct; 41(4):522-5. PubMed ID: 9391253
[TBL] [Abstract][Full Text] [Related]
18. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
Aitola P; Mattila J; Matikainen M
Int J Colorectal Dis; 2000 Jun; 15(3):167-71. PubMed ID: 10954188
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
Ravikumar R; Tsochatzis E; Jose S; Allison M; Athale A; Creamer F; Gunson B; Iyer V; Madanur M; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A
J Hepatol; 2015 Nov; 63(5):1139-46. PubMed ID: 26186988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
